1 in 20 patients hospitalized with COVID-19 developed new-onset Afib, study finds

An analysis of the American Heart Association’s COVID-19 Cardiovascular Disease Registry found 1 in 20 patients hospitalized with COVID-19 developed new-onset Afib.

Advertisement

Researchers from the University of Texas examined nearly 28,000 patients without a history of Afib who developed the condition during hospitalization.

Patients who developed Afib experienced longer hospital stays and greater need for ICU care and intubation. Approximately forty-five percent died in the hospital. The findings suggest that developing Afib is a marker of adverse clinical factors.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

Advertisement